Multi-centre clinical outcomes from Western Australia for a pragmatic one-year pathway for intravesical bacillus Calmette-Guerin

被引：0
|
作者：
Tan, Albert
McCombie, Steve
Moe, Andrew
Viswambaram, Pravin
Dyer, John
Goodwin, Robert
Ha, Tanya
Kuan, Melvyn
Lozinskiy, Mikhail
Hayne, Dickon
机构：
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 16卷
关键词：
CARCINOMA; BLADDER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs24
引用
收藏
页码：43 / 44
页数：2
相关论文
共 30 条
  • [11] Clinical outcomes after intravesical bacillus Calmette-Guerin for the highest-risk non-muscle-invasive bladder cancer newly defined in the Japanese Urological Association Guidelines 2019
    Miyamoto, Tatsuki
    Miyake, Makito
    Toyoshima, Yuta
    Fujii, Tomomi
    Shimada, Keiji
    Nishimura, Nobutaka
    Iida, Kota
    Nakahama, Tomonori
    Hori, Shunta
    Gotoh, Daisuke
    Nakai, Yasushi
    Torimoto, Kazumasa
    Tanaka, Nobumichi
    Ohbayashi, Chiho
    Fujimoto, Kiyohide
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (07) : 720 - 726
  • [12] Re: Sequential bacillus Calmette-Guerin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes Reply
    不详
    JOURNAL OF UROLOGY, 2017, 197 (04): : 1174 - 1174
  • [13] Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guerin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study
    Nishiyama, Naotaka
    Hotta, Hiroshi
    Takahashi, Atsushi
    Yanase, Masahiro
    Itoh, Naoki
    Tachiki, Hitoshi
    Miyao, Noriomi
    Matsukawa, Masanori
    Kunishima, Yasuharu
    Taguchi, Keisuke
    Kitamura, Hiroshi
    Masumori, Naoya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 306.e9 - 306.e15
  • [14] Sequential bacillus Calmette-Guerin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes EDITORIAL COMMENT
    Davenport, Michael T.
    Liao, Joseph C.
    JOURNAL OF UROLOGY, 2016, 195 (06): : 1703 - 1703
  • [15] Health related quality of life after one-year maintenance intravesical Bacillus Calmette-Gurein for non-muscle invasive bladder: experience from a urology centre in Hong Kong
    Ho, B.
    Kan, C. F.
    To, H. C.
    Sze, B.
    Ngai, H. Y.
    Ho, L. Y.
    Au, W. H.
    BJU INTERNATIONAL, 2013, 111 : 4 - 5
  • [16] Results and side effect profile after one-year maintenance intravesical Bacillus Calmette-Gurein for non-muscle invasive bladder: experience from a urology centre in Hong Kong
    Li, T. C. F.
    Kan, C. F.
    To, H. C.
    Sze, B.
    Ngai, H. Y.
    Ho, L. Y.
    Au, W. H.
    Chan, S. W. H.
    BJU INTERNATIONAL, 2013, 111 : 3 - 3
  • [17] Editorial Comment from Dr Matsumoto to Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guerin treatment
    Matsumoto, Kazuhiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (10) : 1130 - 1131
  • [18] A Retrospective Cohort Study on One-Year Mortality Following Emergency Laparotomy: A Tertiary Centre Experience From Western Australia
    Pinto, Mihindukulasuriya Y.
    Frois, Ashley O.
    Weber, Dieter
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [19] Intravesical administration of combined hyaluronic acid and chondroitin sulfate can improve symptoms in patients with refractory bacillus Calmette-Guerin-induced chemical cystitis: Preliminary experience with one-year follow-up
    Imperatore, Vittorio
    Creta, Massimiliano
    Di Meo, Sergio
    Buonopane, Roberto
    Longo, Nicola
    Fusco, Ferdinando
    Spirito, Lorenzo
    Imbimbo, Ciro
    Mirone, Vincenzo
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2018, 90 (01) : 11 - 14
  • [20] Efficacy of Bacillus Calmette-Guerin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial
    Sinha, Sanjeev
    Ajayababu, Anuj
    Thukral, Himanshu
    Gupta, Sushil
    Guha, Subhasish Kamal
    Basu, Ayan
    Gupta, Gaurav
    Thakur, Prashant
    Lingaiah, Raghavendra
    Das, Bimal Kumar
    Singh, Urvashi B.
    Singh, Ravinder
    Narang, Rajiv
    Bhowmik, Dipankar
    Wig, Naveet
    Modak, Dolan Champa
    Bandyopadhyay, Bhaswati
    Chakrabarty, Banya
    Kapoor, Aditya
    Tewari, Satyendra
    Prasad, Narayan
    Hashim, Zia
    Nath, Alok
    Kumari, Niraj
    Goswami, Ravinder
    Pandey, Shivam
    Pandey, Ravindra Mohan
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (06) : 2205 - 2217
123